Culture riding virtual R&D wave, latest funding round enables development of cloud bioreactors

Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, recently announced an $80m Series B round, taking the funds it has raised to date to $100m+.